RecruitingPhase 4NCT07315828

Accuracy of Indocyanine Green (ICG) Fluorescence Imaging in Giant Cell Tumor of Bone Surgery

Studying Giant cell tumor of bone

Last synced from ClinicalTrials.gov April 1, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Shanghai Jiao Tong University Affiliated Sixth People's Hospital
Intervention: Indocyanine Green(drug)
Enrollment: 40 target
Eligibility: 18-75 years · All sexes
Timeline: 2026 – 2026

Study locations (1)

Shanghai Sixth People's Hospital, Shanghai, China

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT07315828 on ClinicalTrials.gov

Other trials for Giant cell tumor of bone

Additional recruiting or active studies for the same condition.

RECRUITINGNCT07227961
PROMIS and Mobility Evaluation in Sarcoma Patients
University of Calgary
RECRUITINGPHASE1, PHASE2NCT06647901
Efficacy of ICG-based NIR Imaging in Intralesional Curettage of Giant Cell Tumors of Bone in Limbs: a Prospective, Single-center, Single-arm, Open Study
Tang Xiaodong
ACTIVE NOT RECRUITINGPHASE4NCT04586660
Study of XGEVA® (Denosumab) in Chinese Adults and Skeletally Mature Adolescents With Giant Cell Tumor of the Bone
Amgen
RECRUITINGPHASE2NCT05595603
Zoledronic Acid-loaded Bone Cement as a Local Adjuvant Therapy for Giant Cell Bone Tumor After Intralesional Curettage
Second Affiliated Hospital, School of Medicine, Zhejiang University
RECRUITINGPHASE3NCT03295981
Local Bisphosphonate Effect on Recurrence Rate in Extremity Giant Cell Tumor of Bone
St. Louis University

See all trials for Giant cell tumor of bone →

← Back to all trials